AzTrials
AzTrials

Child DevelopmentEPIDIA4KidsNCT05577533

Digital Epidemiology Study on Brain Functioning

A study testing O-Kidia game battery and O-Brain in people with Child Development and Child Development Disorder, run by O-Kidia at 2 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Neurobiology has improved the integrative understanding of brain development. With digital technologies, digital (bio)markers would be relevant variables for a better understanding of the heterogeneity of cognitive and behavioral functioning in developing children. Read more about this study

Who is it for?
Ages 7 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Child Development, Child Development Disorder
What is being tested?
O-Kidia game battery and O-Brain
Could I receive a placebo?
No, everyone receives an active treatment
How many people
736 participants
Where
2 sitesFrance
Study dates
21 Mar 2023to 30 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Boys or girls
  • Aged 7 to 12 years
  • Fluent in the French language
  • Agreement and signature of informed consent by the child
  • Agreement and signature of informed consent by one of the legal representatives
  • Estimated intelligence quotient > 85

Who cannot join

  • No biological parent or legal guardian is able to give permission for the minor and agrees to participate in parental assessments
  • Prematurity or other perinatal complications that required significant intervention
  • History of neurological disorders, including seizure disorders, cerebral palsy, or other conditions requiring neurological or medical care :
  • History of head injury:
  • Head trauma more than one year old with loss of consciousness >30 minutes, OR
  • Had to be hospitalized for head trauma, OR
Show all 11Show fewer
  • Amnesia > 24 hours, OR
  • Confusion or loss of orientation >24 hours, OR
  • A brain scan revealed problems following a head injury, OR
  • Head trauma within the past year with loss of consciousness >10 minutes. Current or persistent major Axis I psychiatric disorder that may interfere with successful completion of the protocol (e.g., psychosis and bipolar disorder), or substance use disorder.
  • Current use of medications with significant effects on brain function or blood flow (e.g., antipsychotics, mood stabilizers); Attention Deficit Hyperactivity Disorder (ADHD) medications and Selective Serotonin Reuptake Inhibitors (SSRIs) are not excluded as the use of these medications is associated with certain neurodevelopmental disorders and assessment of these individuals will provide useful data to the community Not fluent in French (all youth materials are in French) Uncorrectable visual, hearing, or sensorimotor impairment, as the protocol items may not be valid.

Trial locations and contacts

2 sites in 1 country.

Vanessa Douet Vannucci, PhD contact

+33768717649

vanessa.douet@o-kidia.com

Théo Marchand, Msc contact

+33622236076

theo.marchand@o-kidia.com

France2 sites, 2 recruiting
  • O-Kidia

    Gardanne, Provence-Alpes-Côte d'Azur Region, 13120

    Vanessa Douet Vannucci, PhD, +33768717649, vanessa.douet@o-kidia.com

    Theo Marchand, Msc, +33633236076

    Recruiting
  • Association la Busserine

    Marseille, Provence Alpes Cotes d'Azur, 13014

    Theo Marchand, MsC, theo.marchand@o-kidia.com

    Vanessa Douet Vannucci, PhD

    Not yet recruiting

Other trials in France

About this study

Official title: Digital Epidemiology Study on Brain Functioning in Children Aged 7 to 12 Years

Neurobiology has improved the integrative understanding of brain development. With digital technologies, digital (bio)markers would be relevant variables for a better understanding of the heterogeneity of cognitive and behavioral functioning in developing children.

However, the dominant statistical approach of group comparison tends to ignore intragroup variability. Applying high-dimensional data sets through multivariate methods and then combining their scores via predictive model learning algorithms would allow the identification of subtypes. Thus, EPIDIA4KIDS wants to understand the brain functioning of children aged 7 to 12 years old from heterogeneous data sources collected from a touchscreen tablet.

Read the detailed description

The overall objective of the EPIDIA4KIDS study is to understand brain functioning in children aged 7 to 12 years from heterogeneous digital data collected with a touch tablet. The investigators want to develop a digital e-screening, similarly to a blood test result, for cognitive, emotional and behavioral performances in children from 7 to 12 years old, resulting from a multimodal and multi-stream analysis generated by an artificial intelligence algorithm.

The main aims are therefore to:

  • Develop a normative base of cognitive, emotional and, behavioral performances with children aged 7 to 12 years old using our digital tool.
  • Examine the validity of our e-assessment by comparing the generated results to those obtained with standard measures of convergent validity.
Being tested
O-Kidia game battery, O-Brain
Keywords
Digital Epidemiology, Child, Neurodevelopment, Neurodevelopmental disorders, Mental disorders
Medical subject headings
Developmental Disabilities, Neurodevelopmental Disorders, Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • O-Kidia game batteryBehavioural

    Children will be playing on a series of games with a touch screen tablet while video and digit trajectories data will be collected from this mobile device to analyze eye-, face-, sound-recognition.

  • O-BrainBehavioural

    Electrical recordings and measurements - A mobile EEG headset will be used during the visit - 30 min

Study groups in NCT05577533
Study groupRoleWhat they receive
O-Kidia batteryOtherA one-time visit will be performed in children aged 7 to 12 years old as follow : Children will be playing on a series of games with a touch screen tablet while video, EEGs and digit trajectories data will be collected from this mobile device 1. Video recording of the participants during the tablet testing via the intrinsic camera - 30 min 2. Assessments - Paper and tablet psychometric tests will be used during the administrations, 1h45 3. Child health questionnaires - Questionnaires will be completed by children and parents during the visit, 20 min for each
Receives: Behavioral: O-Kidia game battery; Behavioral: O-Brain

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Create a Normative Database for emotional, behavioral and cognitive performance

    Measure number of criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    Total errors, Number of errors in total, False responses

    Measured: 24 months

  2. Create a Normative Database for emotional, behavioral and cognitive performance

    Measure number of criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    False responses

    Measured: 24 months

  3. Create a Normative Database for emotional, behavioral and cognitive performance

    Measure number of criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    Number of responses other than omission

    Measured: 24 months

  4. Create a Normative Database for emotional, behavioral and cognitive performance

    Measure number of criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    Hits/Accuracy, Number of correct responses, Hits of correct responses

    Measured: 24 months

  5. Create a Normative Database for emotional, behavioral and cognitive performance

    Measure number of criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    Standard deviation of the 3 standard errors calculated for each task block

    Measured: 24 months

  6. Create a Normative Database for emotional, behavioral and cognitive performance

    Measure number of criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    Order of combination of responses

    Measured: 24 months

  7. Create a Normative Database for emotional, behavioral and cognitive performance

    Time criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of typically developing children when playing with the O-Kidia battery on a touchscreen tablet

    Hits of Reaction time (RT), Median of reaction times for correct responses, Hits RT SE Standard error of Hits RT, Hits RT block change

    Measured: 24 months

  8. Create a Normative Database for emotional, behavioral and cognitive performance

    Time criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of typically developing children when playing with the O-Kidia battery on a touchscreen tablet

    Slope of change in RT between blocks, Slope of change in RT standard errors between blocks

    Measured: 24 months

  9. Create a Normative Database for emotional, behavioral and cognitive performance

    Time criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of typically developing children when playing with the O-Kidia battery on a touchscreen tablet

    SE variability Standard deviation of the 3 standard errors calculated for each task block

    Measured: 24 months

  10. Create a Normative Database for emotional, behavioral and cognitive performance

    Time criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of typically developing children when playing with the O-Kidia battery on a touchscreen tablet

    Order of combination of responses by reaction time

    Measured: 24 months

  11. Create a Normative Database for emotional, behavioral and cognitive performance

    Eye-movement criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    • Eye-tracking associated with O-Kidia battery: Number of saccade (pro/anti-), Number of blinks

    Measured: 24 months

  12. Create a Normative Database for emotional, behavioral and cognitive performance

    Eye-movement for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    • Eye-tracking associated with O-Kidia battery: near-point convergence, Near-point contact point

    Measured: 24 months

  13. Create a Normative Database for emotional, behavioral and cognitive performance

    Eye-movement criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    • Eye-tracking associated with O-Kidia battery: amplitude, direction, direction interval,

    Measured: 24 months

  14. Create a Normative Database for emotional, behavioral and cognitive performance

    Time of eye-movement criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    • Eye-tracking associated with O-Kidia battery: reaction time, fixation, time interval

    Measured: 24 months

  15. Create a Normative Database for emotional, behavioral and cognitive performance

    Digit-movement criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    • Digit-tracking associated with O-Kidia battery : direction, cumulated distance, distance to the proper trajectory

    Measured: 24 months

  16. Create a Normative Database for emotional, behavioral and cognitive performance

    Time of digit-movement criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    • Digit-tracking associated with O-Kidia battery : exploration time, time to the proper trajectory

    Measured: 24 months

  17. Create a Normative Database for emotional, behavioral and cognitive performance

    Velocity of digit-movement criteria for motor skills, emotions, cognition and behavior, and therefore a neurodevelopmental presentation of developing children when playing with the O-Kidia battery on a touchscreen tablet

    Measured: 24 months

  18. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : WISC-V subtests, including Verbal concept, Fluid Reasoning scale, Working Memory measures, Processing Speed abilities

    • Accuracy measures are :Total errors, Number of errors in total

    Measured: 24 months

  19. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : WISC-V subtests, including Verbal concept, Fluid Reasoning scale, Working Memory measures, Processing Speed abilities

    • False responses, Number of responses other than omission

    Measured: 24 months

  20. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : WISC-V subtests, including Verbal concept, Fluid Reasoning scale, Working Memory measures, Processing Speed abilities

    • Number of correct responses, Hits of correct responses

    Measured: 24 months

  21. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : WISC-V subtests, including Verbal concept, Fluid Reasoning scale, Working Memory measures, Processing Speed abilities

    • SE variability Standard deviation of the 3 standard errors calculated for each task block

    Measured: 24 months

  22. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : WISC-V subtests, including Verbal concept, Fluid Reasoning scale, Working Memory measures, Processing Speed abilities

    • Order of combination of responses

    Measured: 24 months

  23. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : WISC-V subtests, including Verbal concept, Fluid Reasoning scale, Working Memory measures, Processing Speed abilities

    • Reaction time (RT) median for correct responses, Hits RT SE Standard error of Hits RT, Hits RT block change

    Measured: 24 months

  24. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : WISC-V subtests, including Verbal concept, Fluid Reasoning scale, Working Memory measures, Processing Speed abilities

    • Slope of change in RT between blocks, Slope of change in RT standard errors between blocks

    Measured: 24 months

  25. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : WISC-V subtests, including Verbal concept, Fluid Reasoning scale, Working Memory measures, Processing Speed abilities

    • SE variability Standard deviation of the 3 standard errors calculated for each task block, Order of combination of responses by reaction time

    Measured: 24 months

  26. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : Event planification abilities, the Tower of London

    Determination of performance at the test of the Tower of London coupled with eye-tracking.

    • Tower of London: analysed variables are: Number of problems solved (maximum duration is one minute) Failure if three successive problems are unsolved Types of error : systematic rule violation, back-and-forth Percentage of problems solved with the execution (minimal) number of moves.
    • Hits/Accuracy Number of correct responses

    The higher score is the better outcome.

    Measured: 18 months

  27. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : Event planification abilities, the Tower of London

    Time for the performance at the test of the Tower of London coupled with eye-tracking.

    • Duration for planification and execution
    • Reaction Time, Total errors
    • Hits RT Median of reaction times for correct responses, Hits RT SE Standard error of Hits RT

    Measured: 18 months

  28. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : Children Behavior Check List (short version, 32 items) 32 items rated on a 3-point Likert-type scale, ranging from "never" (0) to "very often" (3) for the anxiety scale. The higher score is the worse outcome.

    Measured: 24 months

  29. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : Children Behavior Check List (short version, 32 items) 32 items rated on a 3-point Likert-type scale, ranging from "never" (0) to "very often" (3) for the evitant/depression scale. The higher score is the worse outcome.

    Measured: 24 months

  30. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : Children Behavior Check List (short version, 32 items) 32 items rated on a 3-point Likert-type scale, ranging from "never" (0) to "very often" (3) for the social problem scale. The higher score is the worse outcome.

    Measured: 24 months

  31. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : Behavioral assessment of executive function scoring (BRIEF, 72 items)

    72 items rated on a 3-point Likert-type scale, ranging from "never" (1) to "often" (3).The clinical scale gives a well-rounded picture of the behavior of the child or adolescent being rated.

    Measured: 24 months

  32. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : (Keith Conners-3, 108 items)

    -108-items rated on a 4-point Likert-type scale, ranging from "never" (0) to "often" (3) to give insight into ADHD assessment as well as comorbid disorders such as Oppositional Defiant Disorder and Conduct Disorder. The higher score is the worse outcome

    Measured: 24 months

  33. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : Autism Quotient List version scoring (10 items)

    -10-items rated on a 4-point Likert-type scale, ranging from "Strongly agree" (1) to "definitely disagree" (3). Only one point can be awarded for each question. Give 1 point for "Strongly agree" or "Definitely disagree " for questions 1, 5, 7, and 10. Award 1 point for "Strongly Disagree" or "Strongly Disagree" for each of questions 2, 3, 4, 6, 8 and 9. If the person scores 6 or higher, he or she probably has social difficulties requiring referral for a specialized diagnostic assessment.

    Measured: 24 months

  34. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : QTAC scoring, coordination acquisition disorder (15 items)

    15-items rated on a 5-point Likert-type scale, ranging from "not alike" (1) to "extremyly alike disagree" (5). The higher the scores the higher coordination acquisition disorder is suspected.

    Measured: 24 months

  35. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : Inattention and Hyperactivity-Impulsivity components with the ADHD-Rating Scale (18 items)

    • Measure of number of criteria for inattention, hyperactivity-impulsivity and therefore clinical presentation of ADHD (Predominant Inattentive, Predominant Hyperactive-Impulsive, Combined )

    Measured: 24 months

  36. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : Inattention and Hyperactivity-Impulsivity components with the ADHD-Rating Scale (18 items)

    • ADHD Rating Scale: 9 inattention items and 9 hyperactivity-impulsivity items rated on a 0-3 scale (range 0-27), therefore the total score is on a 0-54 range. The higher the scores the higher the inattention and hyperactivity-impulsivity

    Measured: 24 months

  37. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : Perseverance

    • the Grit-Scale for Children (GSCA, 12 items), items rated on a 1-5 scale, therefore the total score is on a 0-60 range, then divided by 12. The maximum score on this scale is 5 (extremely gritty), and the lowest scale on this scale is 1 (not at all gritty).

    Measured: 24 months

  38. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : Motivation

    • the School Motivation Questionnaire (SMQ, 10 min), 30 items on a Five-point Likert-type scale, ranging from "never" (1) to "very often" (5). The SMQ maximum total score is 150 and the minimum is 30 with solid loading scores: Self-Determination (SD), Self-Efficacy (SE), Intrinsic Motivation (IM), and Grade Motivation (GM)

    Measured: 24 months

  39. Convergence validity for the O-Kidia battery

    Describe the subgroup and compare it to pattern of comorbidities : Sleep quality (Pittsburgh Sleep Quality Index, 11 items)

    • The PSQI consists of 11 self-report questions that combine to give 7 "components" of the overall score, with each component receiving a score from 0 to 3. In all cases, a score of 0 indicates no difficulty while a score of 3 indicates severe difficulty. The 7 components of the score are added together to give an overall score ranging from 0 to 21 points, with 0 indicating no difficulty and 21 indicating major difficulty. A global score is the addition of these 7 components.

    Measured: 24 months

Secondary outcomes (11)
  1. Description of participants' characteristics

    Measure of demographics with age

    Measured: 24 months

  2. Description of participants' characteristics

    Measure of language spoken

    Measured: 24 months

  3. Description of participants' characteristics

    Measure of family structure, school, medical history with questionnaires

    Measured: 24 months

  4. Description of participants' characteristics

    Measure of manual laterality, Edinburgh handedness, short version, to indicate manual laterality from 4 items rated on a five-point Likert-type scale, ranging from "always right" to "always left", scoring from +100 to -100.

    Measured: 24 months

  5. Description of participants' characteristics

    Socioeconomic status as measure INSEE index

    Measured: 24 months

  6. mobile EEG biomarkers

    P300 wave amplitude and latency - Quantitative electroencephalography (qEEG) will be recorded during a resting state, Elicitation of evoked potentials (ERP) will use the O-Kidia battery to elicit components associated with attention, working memory, stress, or anxiety

    Measured: 24 months

  7. mobile EEG biomarkers

    P1, N1, P2, N2 and P3 waves, amplitudes and latencies - Elicitation of evoked potentials (ERP) will use the O-Kidia battery to elicit components associated with attention, stress, or anxiety

    Measured: 24 months

  8. mobile EEG biomarkers

    N170 waves, amplitudes and latencies as measures of episodic memory

    Measured: 24 months

  9. mobile EEG biomarkers

    Alpha-, theta, beta waves and their ratios as a measures of ADHD assessments.

    Measured: 24 months

  10. UX/UI feasibility

    Questionnaire (10-items) assessing the usability (UX/UI) for children, on a five-point likert type scale ranging 0 to 50 points, higher scores meaning better outcome.

    Measured: 12 months

  11. Test-retrests for the O-Games battery

    Significant changes of either or both scores at T2 compared with baseline (repeated testing), higher scores meaning better outcome.

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Oct 2022
  2. Study start21 Mar 2023
  3. Primary completion1 Jul 2024 (estimated)
  4. Study completion30 Sep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
736 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05577533
Sponsor's protocol ID
2022-A00766-37
Other IDs
2022-002949-17
Acronym
EPIDIA4Kids
Status last verified
Apr 2023
First submitted
16 Sep 2022
Last updated
19 Oct 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing O-Kidia game battery and O-Brain in people with Child Development and Child Development Disorder, run by O-Kidia at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Vanessa Douet Vannucci, PhD (+33768717649, vanessa.douet@o-kidia.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Create a Normative Database for emotional, behavioral and cognitive performance (time frame: 24 months). The study lists 39 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in